Results 201 to 210 of about 174,816 (264)
Beneficial subgroups for PD-1 inhibitor plus chemotherapy in first-line treatment of advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis. [PDF]
Medicine (Baltimore)Gao R, Wang D, Su L, Zhang X, Dai T.
europepmc +1 more source
Programmed cell death inhibitors: a new hope for cancer therapy? [PDF]
World J Surg OncolZhong Y +5 more
europepmc +1 more source
PANoptosis: a new perspective for targeting programmed cell death after spinal cord injury. [PDF]
Front ImmunolQian Q, Shi L, Xie J, Zhao X, Meng X.
europepmc +1 more source
Cadonilimab plus chemotherapy <i>vs</i>. PD-1 inhibitor plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction cancer with PD-L1 combined positive score <5: a propensity-matched, retrospective cohort study. [PDF]
J Gastrointest OncolZhao D +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Alcohol, 2020
Engagement of programmed death-1 (PD-1) receptor by its ligands (PD-L1/PD-L2) in activated immune cells is known to be involved in inflammatory neurological disease via a co-inhibitory signal pathway. Interaction of PD-1/PD-L1 is believed to occur only in activated neuroimmune cells because there are undetectable levels of PD-1/PD-L1 in normal ...
Vikas Mishra +4 more
openaire +2 more sources
Engagement of programmed death-1 (PD-1) receptor by its ligands (PD-L1/PD-L2) in activated immune cells is known to be involved in inflammatory neurological disease via a co-inhibitory signal pathway. Interaction of PD-1/PD-L1 is believed to occur only in activated neuroimmune cells because there are undetectable levels of PD-1/PD-L1 in normal ...
Vikas Mishra +4 more
openaire +2 more sources
Breast Cancer Research and Treatment, 2021
The interaction of the programmed cell death 1 (PD-1) receptor on tumor-infiltrating lymphocytes with programmed death ligand 1 (PD-L1) on tumor cells downregulates anti-tumor immunity. This study evaluated associations between PD-1 and PD-L1 expression in primary breast cancer, clinical characteristics, and patient outcomes.Microarray data from the ...
Neelima Vidula +2 more
openaire +2 more sources
The interaction of the programmed cell death 1 (PD-1) receptor on tumor-infiltrating lymphocytes with programmed death ligand 1 (PD-L1) on tumor cells downregulates anti-tumor immunity. This study evaluated associations between PD-1 and PD-L1 expression in primary breast cancer, clinical characteristics, and patient outcomes.Microarray data from the ...
Neelima Vidula +2 more
openaire +2 more sources
Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology, 2020
Oral squamous cell carcinoma (OSCC) is a common malignant tumor in the oral and maxillofacial region. At present, the treatment of OSCC is mainly based on surgical oriented comprehensive sequence therapy, especially the triple therapy of surgery, radiotherapy, and chemotherapy. However, the overall five-year survival rate is relatively low.
Zhi-Hong, Chen, Ya-Dong, Wu
openaire +1 more source
Oral squamous cell carcinoma (OSCC) is a common malignant tumor in the oral and maxillofacial region. At present, the treatment of OSCC is mainly based on surgical oriented comprehensive sequence therapy, especially the triple therapy of surgery, radiotherapy, and chemotherapy. However, the overall five-year survival rate is relatively low.
Zhi-Hong, Chen, Ya-Dong, Wu
openaire +1 more source
Decreased T-Cell Programmed Death Receptor-1 Expression in Pregnancy-Associated Melanoma
The American Journal of Dermatopathology, 2019Introduction: Pregnancy depends on tolerance of an immunologically foreign fetus through type 1 T-cell suppression. Worse melanoma outcomes have been described within 1 year of childbirth. We assessed immunopathologic factors that may account for the observed negative impact of pregnancy on outcome.
Jennifer S, Ko +8 more
openaire +2 more sources